SELLAS Life Sciences Group, Inc. (SLS)

3.79 -0.02 (-0.52%) USD  |  NASDAQ  |  Feb 10, 12:53
More

SELLAS Life Sciences Group Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
GT Biopharma, Inc. --
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade